Volker Knappertz, EVP, Research and Development at Aurinia Pharmaceuticals Inc. (AUPH), sold 50,292 shares at $5.48 ($276K) on 2024-02-20, disclosed to the SEC on 2024-02-22.
Open-market sale of $276k AUPH by EVP, Research and Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.48 | 25,146 | $138K | 50.0% |
| 2 | $5.48 | 25,146 | $138K | 50.0% |
| Total | $5.48 avg | 50,292 | $276K | 100% |
| Filing → |
| GWPH | SELL | 2021-01-20 | $70K | — | Filing → |
| GWPH | SELL | 2020-11-25 | $126K | — | Filing → |
| GWPH | SELL | 2020-11-13 | $60K | — | Filing → |